Welcome to our Grand Rounds Series. Each week, we plan to post a summary of the week’s Medicine Grand Rounds lecture. The summaries are reviewed and approved by the grand rounds speaker …
Category: Systems
Clinical Correlations
Inpatient Diabetes Management: Case 6
November 8, 2007
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to Case 6 of our special diabetes series intended to highlight the essentials of …
Vagally-induced Atrial Fibrillation
November 7, 2007
Case by: Alana Choy-Shan, Chief Resident
Commentary by William Slater MD, Associate Professor of Medicine, Division of Cardiology
Following Thanksgiving dinner, a 36 year-old healthy man developed palpitations and heart racing. He was …
Grand Rounds: “Towards Biologically Rational Therapy for Myelodysplastic Sydrome.â€
November 2, 2007Welcome to our new Grand Rounds Series. Each week, we plan to post a summary of the week’s Medicine Grand Rounds lecture. The summaries are reviewed and approved by the grand …
Elevated Total Protein and the Interpretation of Serum Protein Electrophoresis
November 1, 2007Commentary by Jamie Hoffman, MDÂ
A healthy 54 year old man without past medical history presents for a routine physical exam for his insurance company. His blood work reveals a total protein (TP) of 9.4 g/dl and an albumin of 3.0 g/dl. What should be included in this patient’s diagnostic workup?
Targeting Triglycerides
October 31, 2007
Commentary by Josh Remick MD, PGY-3
Hypertriglyceridemia is defined by the NCEP guidelines for treatment as a fasting triglyceride level greater than 200 mg/dL after the target LDL-C level has been achieved (1). When triglyceride …
Inpatient Diabetes Management: Case 5
October 25, 2007
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to Case 5 of our special diabetes series intended to highlight the essentials …
FDA Approves Label Revision for Erectile Dysfunction Drugs
October 24, 2007
Commentary by Kathy Lee, Pharm.D. Pharmacy Practice Resident
On October 18 2007, the FDA announced the approval of labeling changes to erectile dysfunction (ED) drugs in the class known as phosphodiesterase type 5 (PDE-5) …